{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:20:00Z","timestamp":1773037200685,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Although one-step nucleic acid amplification (OSNA), which measures cytokeratin (CK) 19 mRNA copies, is used for intraoperative detection of sentinel lymph node (SN) metastasis, CK19 mRNA copy number may not always accurately reflect total tumor load in the SN. Because number of DNA copies per cell generally has smaller deviation, we hypothesized that detection of tumor-derived mutated DNA in SNs, by targeting genetic mutations in the primary tumor, may provide more accurate results than OSNA. We investigated the\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutation, frequently detected in breast cancer, to explore the potential of this technique for diagnosing SN metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed data from 94 patients who had undergone SN biopsy at Osaka University Hospital (April 2017 to March 2019). Next-generation sequencing was used for mutation analysis of the primary tumor. In cases of\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutations, OSNA lysates were analyzed to detect\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutations in the SN by using droplet digital polymerase chain reaction (ddPCR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutations were detected in 33.0% (31\/94) of primary tumors, 25 of which had hotspot\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutations and included 59 SNs. Of these SNs, 10 were diagnosed as metastasis positive by OSNA and confirmed by ddPCR to have\n                      <jats:italic>PIK3CA<\/jats:italic>\n                      mutations, with no false negatives.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Assessment of tumor-derived mutated DNA in SNs may be a useful technique to detect SN metastasis, as confirmed by ddPCR analysis. Further analyses, using data from a greater number of patients, are necessary to determine whether the results of whole-genome and whole-exome sequencing can be applied to other genes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1658786","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:29:26Z","timestamp":1773034166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of PIK3CA mutations in the lysate of sentinel lymph nodes in patients with early breast cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Sung Ae","family":"Park","sequence":"first","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Osaka International Cancer Institute","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanae","family":"Masunaga","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kin","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Tokui","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Yoshinami","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Tsukabe","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Sota","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Tanei","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Shimazu","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70947-0","article-title":"Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study","volume":"7","author":"Veronesi","year":"2006","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12282-023-01518-6","article-title":"The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition","volume":"31","author":"Honma","year":"2024","journal-title":"Breast Cancer"},{"key":"B5","article-title":"Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer","volume-title":"HealthTech Guid HTG315","year":"2013"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2512","article-title":"One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients","volume":"13","author":"Tsujimoto","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3108-2","article-title":"Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients","volume":"147","author":"Rubio","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2014.05.026","article-title":"One-step nucleic acid amplification assay for intraoperative prediction of non-sentinel lymph node metastasis in breast cancer patients with sentinel lymph node metastasis","volume":"23","author":"Teramoto","year":"2014","journal-title":"Breast"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6633-0","article-title":"Intraoperative nomograms, based on one-step nucleic acid amplification, for prediction of non-sentinel node metastasis and four or more axillary node metastases in breast cancer patients with sentinel node metastasis","volume":"25","author":"Shimazu","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10549-013-2524-z","article-title":"Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients","volume":"139","author":"Peg","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7363","article-title":"Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation","volume":"42","author":"Abe","year":"2019","journal-title":"Oncol Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-011-1712-y","article-title":"Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients","volume":"131","author":"Cho","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1575-2","article-title":"Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RAR\u03b22 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay","volume":"132","author":"Yamamoto","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3892\/ol.2023.14063","article-title":"Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: a diagnostic accuracy study","volume":"26","author":"Park","year":"2023","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13058-020-01284-9","article-title":"Frequency and spectrum of PIK3CA somatic mutations in breast cancer","volume":"45","author":"Mart\u00ednez-S\u00e1ez","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6950-3","article-title":"ASO author reflections: intraoperative nomograms based on one-step nucleic acid amplification","volume":"25","author":"Shimazu","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100787","article-title":"Detection of ctDNA with personalized molecular barcode NGS and its clinical significance in patients with early breast cancer","volume":"13","author":"Yoshinami","year":"2020","journal-title":"Transl Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1038\/s41598-024-62664-1","article-title":"PIK3CA mutations in endocrine-resistant breast cancer","volume":"14","author":"Schagerholm","year":"2024","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26687","article-title":"The prognostic value of PI3K mutational status in breast cancer: a meta-analysis","volume":"119","author":"Sobhani","year":"2018","journal-title":"J Cell Biochem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2019.11.006","article-title":"Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1658786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:29:27Z","timestamp":1773034167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1658786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":22,"alternative-id":["10.3389\/fonc.2026.1658786"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1658786","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1658786"}}